Furthermore, we investigated serum IFNγ/IL10 of propensity score matched patients from the placebo arm of the randomized placebo-controlled trial of Sodium Selenite and Procalcitonin-guided antimicrobial therapy in Severe Sepsis (SISPCT) (17). The gene discussed is IFNG; the disease is Sepsis.